PM, when we get the share price above $5, changes in the governance of the company will be no problem, nor will it be a problem to move to a major exchange once we meet their listing requirements.
NWBO is in a rather unique position, they have many choices as to the direction they go. With owning FlaskWorks, they have all sorts of choices on how they wish to supply DCVax-L to the patient, and none of them are wrong, they're just choices.
I don't know if NWBO will make the DCVax-L themselves, or establish one or more production contracts, or establish FlaskWorks units in many major hospitals and research institutes and let them make the vaccine all over the world. Will they sell, or lease all the FlaskWorks units. Even how they deal with the cassettes offer choices.
Some of these things cost a great deal up front, others cost very little. I believe leasing the units gives them better control and greater earning potential, but it will cost them more up front than selling them. I suppose you could even give the FlaskWorks unit away, but charge $200K for each cassette the recipient wanted.
I'm just suggesting that there are many ways they can run the business, some would have tremendous growth in the size of the company, others would keep it small and let others do the work, all can be quite profitable.
I know that at City of Hope they already have the facilities needed to support FlaskWorks units, leasing or selling them to such places would put the units right together with the patients utilizing them and into laboratories that can already support them. My point is, there are many such institutions all over the world, it could be a viable choice that minimizes transport of the tumors, etc. or the vaccine. Centralized processing will certainly work as well, but transportation and preservation becomes a bigger issue. Shipping an empty cassette is certainly easier than a product which must be cryogenically preserved, but it's really not that hard to transport things in liquid nitrogen in properly designed flasks. Compounding pharmacies all over the world make products as their needed, this may be more complex than that, but not that much more.
Just saying, we have a lot of choices at least until such time as we partner, then they'll have a lot to say. Of course if we're bought out, that will be the end of choices, we'll have made it.
Gary
